Icds Limited - financial services in Karnataka., Karnataka, India. FY 2026 financials & compliance.
CIN L65993KA1971PLC002106 Incorporated 21 October 1971 ROC Bangalore HQ Karnataka., Karnataka, India
Active Listed - NSE: ICDSLTD · BSE: 511194 Public Limited Company financial services
Data last updated
Market Cap
₹76.87 Cr
ICDSLTD · NSE
Share Price
₹56.99
-3.42% today
Revenue
₹2.39 Cr
FY 2025-26 · +15.8% YoY
EBITDA
₹0.26 Cr
Margin 10.9%
Net Profit
₹1.61 Cr
FY 2025-26 · -5.9% YoY
P/E (TTM)
119.1x
P/B 2.6x
ROE
5.5%
ROCE 7.1%
Debt / Equity
0.00
Interest cover -50.0x

About Icds Limited

Data last updated: 25 September 2026

Icds Limited is a public limited company based in Karnataka., Karnataka, India. It specialises in non-banking financial services (NBFC), a part of the broader financial services sector. Incorporated on 21 October 1971, the company has been in operation for over 55 years.

Registered with ROC Bangalore under CIN L65993KA1971PLC002106. Listed on BSE: 511194 and NSE: ICDSLTD.

Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹13.03 Cr. It is led by directors including Sujir Prabhakar and Sachin Tonse Pai.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Syndicate House Upendra Nagar Manipal, Karnataka., Karnataka, India – 576104.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹2.39 Cr, a decline of 38.72% compared to the previous year. The net worth stands at ₹29.97 Cr (up 3.52% YoY). Total assets are valued at ₹30.53 Cr (up 2.52% YoY).

The company has a workforce of approximately 12 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Icds Limited.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website icdslimited.com.

Company Details of Icds Limited
CIN L65993KA1971PLC002106
Registration Number 002106
Incorporation Date 21 October 1971
ROC Bangalore
Listing Status Listed (BSE: 511194, NSE: ICDSLTD)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Syndicate House Upendra Nagar Manipal, Karnataka., Karnataka, India – 576104
  • Industry
    Financial Services, NBFC
Company report
Icds Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Icds Limited report

Financials, compliance, directors, charges, ownership and filings for Icds Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Icds Limited

Icds Limited has one previous CIN (Corporate Identification Number): U65993KA1971PLC002106. The current CIN is L65993KA1971PLC002106, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L65993KA1971PLC002106 Current
U65993KA1971PLC002106 Previous

Associated Brands with Icds Limited

Icds Limited operates one associated brand: ICDS Limited. These brands represent Icds Limited's diversified market presence and brand portfolio.

Brand Description Website
Financial services are provided by ICDS in India since 1971. icdslimited.com

Competitors & Alternatives of Icds Limited

Brands and companies operating in the same space as Icds Limited include Prudent, Reliance Capital, Equentis Wealth Advisory Services and 4 more.

Competitor Description Location Founded
Prudent Prudent Provider of financial products and investment services Ahmedabad, India, India 2000
Reliance Capital Reliance Capital Financial services including loans, insurance, and asset management are provided. Mumbai, India, India 1986
Equentis Wealth Advisory Services Equentis Wealth Advisory Services Investment advisory and research platform Mumbai, India, India 2015
Kotak Mutual Fund Kotak Mutual Fund Financial advisory services are offered by Kotak Mutual Fund. Mumbai, India, India 1985
Auctus Advisors Auctus Advisors Strategic consulting and advisory services for management decisions are provided. Mumbai, India, India 2010
Quadeye Quadeye Financial advisory services are provided by Quadeye to clients. Gurugram, India, India 2007
Synechron Synechron Synechron is recognized as a global technology and AI consulting firm. New York, United States, United States 2001

Business Activity of Icds Limited

Icds Limited is engaged in multiple principal business activities such as financial and insurance service, trade, and real estate, with detailed activities including financial and credit leasing activities, retail trading, real estate activities with own or leased property. The company has 3 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
K Financial and insurance Service K5 Financial and Credit leasing activities Locked
G Trade G2 Retail Trading Locked
L Real Estate L1 Real estate activities with own or leased property Locked
Premium access

Business activity turnover details for Icds Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Icds Limited

Icds Limited is audited by CHATURVEDI & SHAH LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
CHATURVEDI & SHAH LLP Locked Locked Locked
Premium access

Complete auditor history for Icds Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Icds Limited

Icds Limited is currently managed by 6 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sujir Prabhakar Managing Director 05 Dec 2018 7 Years 9 Months Current
Sachin Tonse Pai Director 05 Dec 2018 7 Years 9 Months Current
Kalsank Umesh Kini Director 24 Feb 2023 3 Years 7 Months Current
Jayaram Vittal Prabhu Director 26 Sep 2024 2 Years 0 Months Current
Roopashree Roopashree Director 04 Dec 2023 2 Years 9 Months Current
Katapady Bhujangesha Kamath Director 04 Dec 2023 2 Years 9 Months Current

Financials of Icds Limited FY 2025-26 filings available

Icds Limited reported revenue of ₹2.39 Cr (down 38.72% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2.39 Cr
-38.7% YoY
EBITDA
₹0.26 Cr
-87.4% YoY
Profit After Tax
₹1.61 Cr
-5.8% YoY
Net Worth
₹29.97 Cr
+3.5% YoY
Total Assets
₹30.53 Cr
+2.5% YoY
Total Debt
₹0.00 Cr
-100.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2.393.902.281.921.421.053.11
Revenue growth+15.8%+28.7%-20.6%+8.4%-2.9%-54.8%-28.4%
EBITDA0.262.060.850.12(0.24)(0.66)(0.67)
EBITDA margin+10.9%+52.8%+37.3%+6.3%-16.9%-62.9%-21.5%
Profit before tax1.362.932.370.535.951.03(0.73)
Net profit1.611.712.050.37(0.57)(5.37)(1.13)
Net profit margin+67.4%+43.9%+89.9%+19.3%-40.1%-511.4%-36.3%
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
Balance sheet
Total assets30.5329.7828.1926.5526.2620.2225.47
Net worth29.9728.9527.5425.5225.2219.3724.84
Total debt0.000.260.130.300.480.140.20
Cash & bank4.171.913.555.202.102.543.13
Net working capital8.475.979.715.368.552.522.81
Cash flow
Cash from operations1.621.060.206.36(0.54)(0.88)(1.92)
Cash from investing(0.83)(1.42)0.23(6.17)0.230.912.46
Cash from financing(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.610.520.570.530.772.350.510.53
Revenue growth (YoY)-20.8%-77.9%+11.8%0.0%+48.1%+231.0%+2.0%-7.0%
Other income1.120.060.38(0.17)1.27(0.48)0.390.70
EBITDA0.00(0.44)0.250.100.361.510.160.26
EBITDA margin0.0%-84.6%+43.9%+18.9%+46.8%+64.3%+31.4%+49.1%
Depreciation0.090.100.100.090.090.090.090.09
Interest0.020.010.020.010.020.020.020.02
Profit before tax1.01(0.49)0.51(0.17)1.520.920.440.85
Tax0.08(0.08)0.070.130.150.081.220.20
Net profit0.93(0.41)0.44(0.30)1.370.84(0.78)0.65
EPS (₹)0.72(0.32)0.35(0.24)1.060.64(0.59)0.50
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1.653.181.571.331.032.833.21
Revenue growth+15.3%+32.3%-16.9%+1.9%-3.1%-55.3%-30.1%
EBITDA(0.38)1.420.24(0.27)(0.54)1.21(0.41)
EBITDA margin-23.0%+44.7%+15.3%-20.3%-52.4%+42.8%-12.8%
Profit before tax0.562.181.750.165.680.89(0.43)
Net profit0.981.131.560.06(0.84)(5.47)(0.80)
Net profit margin+59.4%+35.5%+99.4%+4.5%-81.6%-193.3%-24.9%
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
Balance sheet
Total assets25.6725.5324.6023.2223.4317.6023.16
Net worth25.3424.9524.1422.5922.6116.9722.53
Total debt0.000.260.130.300.480.140.20
Cash & bank3.141.463.494.481.902.531.15
Net working capital6.424.518.754.688.362.581.20
Cash flow
Cash from operations1.190.64(0.28)5.85(0.73)(0.86)(1.58)
Cash from investing(0.59)(1.00)0.71(5.65)0.400.962.05
Cash from financing(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.420.330.390.350.592.160.330.35
Revenue growth (YoY)-28.8%-84.7%+18.2%0.0%+73.5%+307.6%+3.1%-10.3%
Other income1.060.000.33(0.22)1.23(0.53)0.340.66
Total expenses0.550.940.300.410.380.820.330.25
EBITDA(0.13)(0.61)0.09(0.06)0.211.340.000.10
EBITDA margin-31.0%-184.8%+23.1%-17.1%+35.6%+62.0%0.0%+28.6%
Depreciation0.090.090.090.090.090.090.090.09
Interest0.010.010.010.010.010.010.010.01
Profit before tax0.83(0.71)0.32(0.38)1.340.710.240.66
Tax0.04(0.12)0.030.090.110.031.180.16

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 25 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.610.520.570.530.772.350.510.53
Revenue growth (YoY)-20.8%-77.9%+11.8%0.0%+48.1%+231.0%+2.0%-7.0%
Other income1.120.060.38(0.17)1.27(0.48)0.390.70
EBITDA0.00(0.44)0.250.100.361.510.160.26
EBITDA margin0.0%-84.6%+43.9%+18.9%+46.8%+64.3%+31.4%+49.1%
Depreciation0.090.100.100.090.090.090.090.09
Interest0.020.010.020.010.020.020.020.02
Profit before tax1.01(0.49)0.51(0.17)1.520.920.440.85
Tax0.08(0.08)0.070.130.150.081.220.20
Net profit0.93(0.41)0.44(0.30)1.370.84(0.78)0.65
EPS (₹)0.72(0.32)0.35(0.24)1.060.64(0.59)0.50
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2.393.902.281.921.421.053.11
Revenue growth+15.8%+28.7%-20.6%+8.4%-2.9%-54.8%-28.4%
Other income1.541.321.960.836.592.110.37
Total expenses2.131.841.431.801.661.713.78
Employee cost0.480.550.660.730.610.740.86
EBITDA0.262.060.850.12(0.24)(0.66)(0.67)
EBITDA margin+10.9%+52.8%+37.3%+6.3%-16.9%-62.9%-21.5%
Depreciation0.380.370.360.360.330.340.35
Interest0.060.080.080.060.070.080.08
Profit before tax1.362.932.370.535.951.03(0.73)
Tax0.281.530.320.160.106.400.11
Net profit1.611.712.050.37(0.57)(5.37)(1.13)
Net profit margin+67.4%+43.9%+89.9%+19.3%-40.1%-511.4%-36.3%
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital13.0313.0313.0313.0313.0313.0313.03
Reserves & surplus16.9415.9214.5112.4912.196.3411.81
Shareholders' funds (net worth)29.9728.9527.5425.5225.2219.3724.84
Minority interest0.000.000.000.000.000.000.00
Secured loans0.000.260.130.300.480.140.20
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.260.130.300.480.140.20
Total liabilities30.5329.7828.1926.5526.2620.2225.47
Assets
Gross block12.2612.2212.1112.1512.1411.8511.85
Net block9.409.739.9910.3810.7310.7811.12
Capital work in progress0.000.000.000.000.000.000.00
Investments5.155.815.824.344.154.542.50
Inventories0.000.000.000.000.000.000.00
Sundry debtors0.090.090.180.080.070.110.11
Cash & bank balances4.171.913.555.202.102.543.13
Loans & advances6.616.396.460.366.730.130.10
Total current assets10.878.3910.195.648.902.783.34
Total current liabilities2.402.420.480.280.350.260.53
Net working capital8.475.979.715.368.552.522.81
Total assets30.5329.7828.1926.5526.2620.2225.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.080.330.070.080.070.120.12
Net cash from operating activities1.621.060.206.36(0.54)(0.88)(1.92)
Net cash from investing activities(0.83)(1.42)0.23(6.17)0.230.912.46
Net cash from financing activities(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
Net change in cash0.52(0.25)0.25(0.01)0.01(0.04)(0.01)
Closing cash4.171.913.555.202.102.543.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-38.7%+71.1%+18.8%+35.2%+35.2%-66.2%-5.2%
EBITDA growth-87.4%+142.4%+608.3%+9998.0%+63.6%+1.5%+66.5%
PBT growth-53.6%+23.6%+347.2%-91.1%+477.7%+9998.0%+58.1%
Net income growth-5.9%-16.6%+454.1%+9998.0%+89.4%-375.2%+39.3%
Revenue CAGR (3Y)+7.6%+40.0%+29.5%-14.9%-24.4%-45.4%+3.6%
EBITDA CAGR (3Y)+29.4%----50.7%--
Profitability & leverage
Net income margin+45.2%+35.9%+89.9%+19.3%+412.0%-511.4%-27.0%
Return on capital employed+7.1%+11.6%+9.0%+2.2%-2.2%0.0%-3.6%
Return on net worth+5.5%+6.1%+7.7%+1.5%-2.6%0.0%-4.4%
Debt / equity0.000.010.010.020.010.010.02
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-50.004.7316.33-25.00-12.28-8.00-7.84
Efficiency & per share
Fixed asset turnover0.200.320.190.160.670.090.35
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover26.5628.8917.5425.6089.009.5536.63
EPS (₹)0.841.081.560.294.48(4.13)(0.62)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)23.0022.2221.1419.5919.3614.8619.06
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.420.330.390.350.592.160.330.35
Revenue growth (YoY)-28.8%-84.7%+18.2%0.0%+73.5%+307.6%+3.1%-10.3%
Other income1.060.000.33(0.22)1.23(0.53)0.340.66
Total expenses0.550.940.300.410.380.820.330.25
EBITDA(0.13)(0.61)0.09(0.06)0.211.340.000.10
EBITDA margin-31.0%-184.8%+23.1%-17.1%+35.6%+62.0%0.0%+28.6%
Depreciation0.090.090.090.090.090.090.090.09
Interest0.010.010.010.010.010.010.010.01
Profit before tax0.83(0.71)0.32(0.38)1.340.710.240.66
Tax0.04(0.12)0.030.090.110.031.180.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1.653.181.571.331.032.833.21
Revenue growth+15.3%+32.3%-16.9%+1.9%-3.1%-55.3%-30.1%
Other income1.331.151.900.816.590.060.37
Total expenses2.031.761.331.601.571.623.62
Employee cost0.480.550.660.730.610.740.85
EBITDA(0.38)1.420.24(0.27)(0.54)1.21(0.41)
EBITDA margin-23.0%+44.7%+15.3%-20.3%-52.4%+42.8%-12.8%
Depreciation0.360.350.350.350.320.320.33
Interest0.030.040.040.030.050.060.06
Profit before tax0.562.181.750.165.680.89(0.43)
Tax0.111.370.190.100.066.360.07
Net profit0.981.131.560.06(0.84)(5.47)(0.80)
Net profit margin+59.4%+35.5%+99.4%+4.5%-81.6%-193.3%-24.9%
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital13.0313.0313.0313.0313.0313.0313.03
Reserves & surplus12.3111.9211.119.569.583.949.50
Shareholders' funds (net worth)25.3424.9524.1422.5922.6116.9722.53
Secured loans0.000.260.130.300.480.140.20
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.260.130.300.480.140.20
Total liabilities25.6725.5324.6023.2223.4317.6023.16
Assets
Gross block9.409.369.269.299.298.998.99
Net block6.707.017.267.637.987.998.32
Capital work in progress0.000.000.000.000.000.000.00
Investments5.275.925.944.454.264.652.61
Inventories0.000.000.000.000.000.000.00
Sundry debtors0.090.090.180.080.070.080.11
Cash & bank balances3.141.463.494.481.902.531.15
Loans & advances5.375.165.260.356.720.190.22
Total current assets8.606.718.934.918.692.801.48
Total current liabilities2.182.200.180.230.330.220.28
Net working capital6.424.518.754.688.362.581.20
Total assets25.6725.5324.6023.2223.4317.6023.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.050.300.050.050.060.040.11
Net cash from operating activities1.190.64(0.28)5.85(0.73)(0.86)(1.58)
Net cash from investing activities(0.59)(1.00)0.71(5.65)0.400.962.05
Net cash from financing activities(0.27)0.11(0.18)(0.20)0.31(0.08)(0.54)
Net change in cash0.33(0.25)0.250.00(0.02)0.02(0.07)
Closing cash3.141.463.494.481.902.531.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-48.1%+102.6%+18.1%+29.1%-63.6%-11.8%+5.3%
EBITDA growth-+491.7%+9998.0%+50.0%-+9998.0%+80.8%
PBT growth-74.3%+24.6%+993.8%-97.2%+538.2%+9998.0%+76.5%
Net income growth-13.3%-27.6%+2500.0%+9998.0%+84.6%-583.8%+56.5%
Revenue CAGR (3Y)+7.5%+45.6%-17.8%-25.5%-30.4%-25.0%+6.5%
EBITDA CAGR (3Y)+12.1%--41.7%-13.0%-36.7%-37.3%-
Profitability & leverage
Net income margin+27.3%+25.5%+99.4%+4.5%+545.6%-193.3%-15.6%
Return on capital employed+5.1%+10.3%+7.5%+0.8%-3.9%0.0%-2.9%
Return on net worth+3.9%+4.6%+6.7%+0.3%-4.2%0.0%-3.5%
Debt / equity0.010.010.010.020.020.010.02
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-4.053.74-36.36-4.84-5.816.74-8.11
Efficiency & per share
Fixed asset turnover0.180.340.170.140.830.320.51
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover18.3323.5612.0817.73101.6030.4237.68
EPS (₹)0.360.621.190.054.32(4.20)(0.38)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)19.4519.1518.5317.3417.3513.0317.29
Want more history and ratios?
You're viewing the latest exchange-filed financials for Icds Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Icds Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 51.40%, foreign institutional investors hold 0.00%, domestic institutional investors hold 4.90%, retail and other public shareholders hold 43.70% of Icds Limited.

Promoters: 51.40%DII (Domestic Institutional): 4.90%Retail & Others: 43.70%
Jun 2026
QUARTER
51.40% Promoters
4.90% DII (Domestic Institutional)
43.70% Retail & Others
Promoter holding - history
Now 51.40% · Jun 2026High 51.40% · Sep 2025Low 51.40% · Sep 2025
50%50.8%51.5%52.3%53%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 51.40%Dec 2025: 51.40%Mar 2026: 51.40%Jun 2026: 51.40%51.40%51.40%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters51.40%51.40%51.40%51.40%
Public48.60%48.60%48.60%48.60%

Group Structure of Icds Limited

Icds Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Icds Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Manipal Properties Limited U45201TN1999PLC043271 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings Icds Limited

Icds Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Icds Limited

Icds Limited has a workforce of 12 employees as of Mar 23, 2024.

Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
Premium access

Employee and EPFO history for Icds Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Icds Limited

Premium access

GST registrations and filing compliance for Icds Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Icds Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Icds Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Icds Limited

Premium access

MSME payment history for Icds Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Icds Limited

Premium access

Corporate group structure for Icds Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Icds Limited

Premium access

MCA filings and documents for Icds Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Icds Limited

Activity
25 Sep 2025
Icds Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Icds Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Directors
26 Sep 2024
Jayaram Vittal Prabhu was appointed as a Director on 26 Sep 2024 & has been associated with this company since 2 years.
Directors
04 Dec 2023
Roopashree Roopashree was appointed as a Director on 04 Dec 2023 & has been associated with this company since 2 years 9 months.
Directors
04 Dec 2023
Katapady Bhujangesha Kamath was appointed as a Director on 04 Dec 2023 & has been associated with this company since 2 years 9 months.
Directors
04 Aug 2023
Vasudeva Nayak was appointed as a CFO on 04 Aug 2023 & has been associated with this company since 3 years 1 month.

Frequently Asked Questions about Icds Limited

Icds Limited is an active public limited company in the financial services sector based in Karnataka, Karnataka, India. It was incorporated on 21 October 1971 (55+ years old) and is registered under CIN L65993KA1971PLC002106. Listed on BSE: 511194 and NSE: ICDSLTD. The company has 12 employees.

Icds Limited reported revenue of ₹2.39 Cr for FY 2025-26 (down 38.72% YoY) based on consolidated financials.

The current directors of Icds Limited are:

The primary industry of Icds Limited is financial services. The company specifically operates in nbfc. The company is currently active in this sector.

Yes. Icds Limited is listed on both BSE (code: 511194) and NSE (symbol: ICDSLTD).

Icds Limited can be reached at the registered office: Syndicate House Upendra Nagar Manipal, Karnataka, Karnataka, India – 576104, or through the website icdslimited.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available